The amniotic membrane (AM) is a thin membranous structure surrounding the embryo on the fetal side of placenta. The growing population of patients with ophthalmology diseases, orthopedic diseases, and surgeries are increasing the popularity of amniotic membranes among physicians to prefer amniotic membranes. Therefore, it opens doors for different manufacturers to provide innovative amniotic membrane products allowing the surgeons to perform these surgeries in a more efficient way.
Amniotic Membrane Market size was valued at USD 4.5 billion in 2023 and is poised to grow from USD 5.18 billion in 2024 to USD 15.95 billion by 2032, growing at a CAGR of 15.1% during the forecast period (2025-2032).
Increasing need for tissue-based products during ophthalmic surgeries as they help patients recover faster is also expected to go a long way in driving the amniotic membrane market growth. Furthermore, increasing demand for aesthetic surgical procedures is expected to propel the market players during the forecast period. Technology in amniotic membrane has evolved with the advancements in cryopreservation techniques, bioengineering and tissue engineering, biocompatible scaffolds harvesting amniotic fluid-derived products, topical formulations. Improved tissue repair, regeneration and regenerative modulation are created by these innovations.
Get a Free Sample PDF of the Report – https://www.skyquestt.com/sample-request/amniotic-membrane-market
Detailed Segmentation and Classification of the report (Market Size and Forecast – 2032, Y-o-Y growth rate, and CAGR):
The Amniotic Membrane Market can be segmented based on several factors, including product type, application, end-user, and distribution channel.
Global Amniotic Membrane Market is segmented by Product, Application, End Use and region.
Based on Product, the market is segmented into Cryopreserved Amniotic Membrane and Dehydrated Amniotic Membrane.
Based on Application, the market is segmented into Surgical Wounds, Ophthalmology and Others.
Based on End Use, the market is segmented into Hospitals, Ambulatory Surgical Centers, Specialty Clinics and Research Institutes and Academic Institutes.
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Amniotic Membrane Market – Regional Analysis:
In 2023, the overall global Amniotic Membrane Market was dominated by North America and generated the largest amniotic membrane market share across all regions. The growth in this region is primarily due to established healthcare infrastructure and leading players operating in the field. High availability of regenerative medicine and rising adoption of novel technologies is a major driver to bolster the amniotic membrane market growth across this region.
Asia Pacific amniotic membrane market is expected to be growing with fastest growth over the forecast period. For the upcoming period, Asia Pacific market is expected to hold a leading position. In addition, the growing number of trained professionals, along with developing healthcare facilities is expected to fuel the market growth throughout the forecast period.
Top Market Players in Amniotic Membrane Market are:
MiMedx Group, Inc. (USA)
Integra LifeSciences Holdings Corporation. (USA)
Organogenesis Holdings Inc. (USA)
Smith & Nephew plc. (UK)
BioTissue Holdings Inc. (USA)
Amnio Technology, LLC. (USA)
Applied Biologics LLC. (USA)
Celularity Inc. (USA)
Corza Health, Inc. (USA)
Skye Biologics, Inc. (USA)
Human Regenerative Technologies, LLC. (USA)
Katena Products Inc. (USA)
TissueTech Inc. (BioTissue) (USA)
Amniox Medical Inc. (USA)
Laboratoire CCD. (France)
VIVEX Biologics Inc. (USA)
Merakris Therapeutics. (USA)
Thea Pharma (France)
Allosure, Inc. (USA)
Xtant Medical Holdings Inc. (USA)
Amniotic Membrane Market Recent Developments:
In September 2023, MiMedx Group, Inc. recently announced the introduction of EPIEFFECT, its newest advanced wound care (AWC) solution. The triple-layer thickness of the product also allows for sutured fixation of the graft. The properties of its product and handling characteristics render it a more favorable treatment option for deep or tunneling wounds.
In January 2023, MiMedx Group, Inc., the pioneer and leader in placental biologics announced that it has signed a distribution agreement with subsidiary Gunze Medical Limited to exclusively distribute EPIFIX for sale within Japan. The partnership proved beneficial for MiMedx as it not only helped in having a strategic edge but also expanded its market presence of innovative wound care solutions in Japan.
In February 2022, Amnio Technology, a developer and distributor of amniotic tissue allografts, has announced the release of two new PalinGen membrane products – PalinGen Dual-Layer Membrane & Dual Layer PalinGen X-Membrane. These new allografts, similar to each of the range of PalinGen membrane products, are highly low-controlled, homologous use and chorion free.
You may Also Like
https://medium.com/@kathan.trivedi/%ED%8F%90%EA%B8%B0%EB%AC%BC-%EC%97%90%EB%84%88%EC%A7%80-%EC%8B%9C%EC%9E%A5-%EC%A7%80%EC%86%8D-%EA%B0%80%EB%8A%A5%ED%95%9C-%ED%8F%90%EA%B8%B0%EB%AC%BC-%EA%B4%80%EB%A6%AC-%EC%86%94%EB%A3%A8%EC%85%98%EC%9D%98-%EC%84%A0%EA%B5%AC%EC%9E%90-a9be16d2eb52
https://medium.com/@kathan.trivedi/%EC%97%B0%EB%A3%8C-%EC%82%B0%EC%97%85%EC%9D%98-ai-%EB%8F%99%ED%96%A5-%ED%98%81%EC%8B%A0-%EB%B0%8F-%EB%AF%B8%EB%9E%98-%EC%A0%84%EB%A7%9D-4f13ad2f6dcb
Forward-Looking Insights
The Amniotic Membrane Market is set to experience sustained growth, fueled by technological advancements, broader global market access, and rising industry demand. With the industry addressing emerging challenges and capitalizing on new opportunities, it is expected to drive innovation and play a pivotal role in advancing global health and economic progress.
About Company:
SkyQuest is an IP focused Research and Investment Bank and Accelerator of Technology and assets. We provide access to technologies, markets and finance across sectors viz. Life Sciences, CleanTech, AgriTech, NanoTech and Information & Communication Technology.
We work closely with innovators, inventors, innovation seekers, entrepreneurs, companies and investors alike in leveraging external sources of R&D. Moreover, we help them in optimizing the economic potential of their intellectual assets. Our experiences with innovation management and commercialization have expanded our reach across North America, Europe, ASEAN and Asia Pacific.
Contact Details:
SkyQuest Technology Group
USA (+1) 351-333-4748
Email: [email protected]”
